These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 17947294)
21. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model. Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034 [TBL] [Abstract][Full Text] [Related]
22. Immiscible inclusion bodies formed by polyglutamine and poly(glycine-alanine) are enriched with distinct proteomes but converge in proteins that are risk factors for disease and involved in protein degradation. Radwan M; Lilley JD; Ang CS; Reid GE; Hatters DM PLoS One; 2020; 15(8):e0233247. PubMed ID: 32857759 [TBL] [Abstract][Full Text] [Related]
23. Inefficient degradation of truncated polyglutamine proteins by the proteasome. Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501 [TBL] [Abstract][Full Text] [Related]
24. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins. Mitsui K; Nakayama H; Akagi T; Nekooki M; Ohtawa K; Takio K; Hashikawa T; Nukina N J Neurosci; 2002 Nov; 22(21):9267-77. PubMed ID: 12417652 [TBL] [Abstract][Full Text] [Related]
25. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Chai Y; Shao J; Miller VM; Williams A; Paulson HL Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819 [TBL] [Abstract][Full Text] [Related]
26. Polyglutamine domain proteins with expanded repeats bind neurofilament, altering the neurofilament network. Nagai Y; Onodera O; Strittmatter WJ; Burke JR Ann N Y Acad Sci; 1999; 893():192-202. PubMed ID: 10672238 [TBL] [Abstract][Full Text] [Related]
27. Ataxin-1 fusion partners alter polyQ lethality and aggregation. Rich T; Varadaraj A PLoS One; 2007 Oct; 2(10):e1014. PubMed ID: 17925862 [TBL] [Abstract][Full Text] [Related]
28. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Fu L; Gao YS; Sztul E Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198 [TBL] [Abstract][Full Text] [Related]
29. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Arrasate M; Mitra S; Schweitzer ES; Segal MR; Finkbeiner S Nature; 2004 Oct; 431(7010):805-10. PubMed ID: 15483602 [TBL] [Abstract][Full Text] [Related]
30. Evidence for a recruitment and sequestration mechanism in Huntington's disease. Preisinger E; Jordan BM; Kazantsev A; Housman D Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302 [TBL] [Abstract][Full Text] [Related]
31. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase. Scappini E; Koh TW; Martin NP; O'Bryan JP Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941 [TBL] [Abstract][Full Text] [Related]
33. Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Mukai H; Isagawa T; Goyama E; Tanaka S; Bence NF; Tamura A; Ono Y; Kopito RR Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10887-92. PubMed ID: 16040812 [TBL] [Abstract][Full Text] [Related]
34. A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP-->YFP fluorescence resonance energy transfer (FRET). He L; Olson DP; Wu X; Karpova TS; McNally JG; Lipsky PE Cytometry A; 2003 Oct; 55(2):71-85. PubMed ID: 14505312 [TBL] [Abstract][Full Text] [Related]
35. Antisense downregulation of mutant huntingtin in a cell model. Hasholt L; Abell K; Nørremølle A; Nellemann C; Fenger K; Sørensen SA J Gene Med; 2003 Jun; 5(6):528-38. PubMed ID: 12797118 [TBL] [Abstract][Full Text] [Related]
36. Protein transduction domain-mediated delivery of QBP1 suppresses polyglutamine-induced neurodegeneration in vivo. Popiel HA; Nagai Y; Fujikake N; Toda T Mol Ther; 2007 Feb; 15(2):303-9. PubMed ID: 17235308 [TBL] [Abstract][Full Text] [Related]
37. F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics. Angeli S; Shao J; Diamond MI PLoS One; 2010 Feb; 5(2):e9053. PubMed ID: 20140226 [TBL] [Abstract][Full Text] [Related]
38. Mutant huntingtin forms in vivo complexes with distinct context-dependent conformations of the polyglutamine segment. Persichetti F; Trettel F; Huang CC; Fraefel C; Timmers HT; Gusella JF; MacDonald ME Neurobiol Dis; 1999 Oct; 6(5):364-75. PubMed ID: 10527804 [TBL] [Abstract][Full Text] [Related]
39. Expanded polyglutamine stretches form an 'aggresome'. Shimohata T; Sato A; Burke JR; Strittmatter WJ; Tsuji S; Onodera O Neurosci Lett; 2002 May; 323(3):215-8. PubMed ID: 11959423 [TBL] [Abstract][Full Text] [Related]
40. Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Reid SJ; Rees MI; van Roon-Mom WM; Jones AL; MacDonald ME; Sutherland G; During MJ; Faull RL; Owen MJ; Dragunow M; Snell RG Neurobiol Dis; 2003 Jun; 13(1):37-45. PubMed ID: 12758065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]